SLS BIO Co (XKRX:246250) Ending Cash Position : ₩1,557 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co Ending Cash Position?

SLS BIO Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩1,557 Mil.

SLS BIO Co's quarterly Ending Cash Position increased from Sep. 2023 (₩1,731 Mil) to Dec. 2023 (₩1,822 Mil) but then declined from Dec. 2023 (₩1,822 Mil) to Mar. 2024 (₩1,557 Mil).

SLS BIO Co's annual Ending Cash Position increased from Dec. 2021 (₩1,381 Mil) to Dec. 2022 (₩1,527 Mil) and increased from Dec. 2022 (₩1,527 Mil) to Dec. 2023 (₩1,822 Mil).

SLS BIO Co Ending Cash Position Historical Data

The historical data trend for SLS BIO Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co Ending Cash Position Chart

SLS BIO Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

676.67

90.76

1,380.64

1,526.69

1,821.53

SLS BIO Co Quarterly Data
	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial			878.32	1,479.24	1,731.41	1,821.53	1,557.44

SLS BIO Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

SLS BIO Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1526.687	+	294.839
	=	1,822

SLS BIO Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1821.526	+	-264.086
	=	1,557

SLS BIO Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

SLS BIO Co (XKRX:246250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229

Website

http://www.slabs.co.kr

SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines